This Is MS Multiple Sclerosis Knowledge & Support Community

Multiple Sclerosis Newsletter - October Issue Long Term Data on Avonex, Copaxone New results from studies that looked at long-term use of Avonex (interferon beta-1a) and Copaxone (glatiramer acetate) showed that on average both stabilized or reduced disability. Both studies followed-up on people wh...